| Description | This product is a monoclonal antibody derived from Mouse (Mus musculus), which can specifically recognize Advanced glycosylation end product-specific receptor. The antibody is expressed with mammalian cell transient expression system, serum-free and purified by affinity chromatography. The purity and integrity are tested via SDS-PAGE and SEC-HPLC analysis. Given an antigen, additional QC measures are also desired such as affinity testing and binding validation. Specifically, the antibody is provided in multiple formats for in vivo and in vitro assays. The Invivo version features greater than 95% purity, ultra-low endotoxin levels (<1 EU/mg or 0.1 EU/mg), and is preservative, stabilizer, and carrier protein-free. |
| Clonality | Monoclonal |
| Host Species | Mouse |
| Target Species | Human, Mouse |
| Immunogen | Human RAGE |
| Epitope | The epitope is in C1 (Asn105- Pro215). |
| Affinity | KD = 0.1 nM, determined by surface plasmon resonance. |
| Isotype | IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and/or SEC-HPLC |
| Endotoxin | <1 EU/mg, determined by LAL method |
| Purification | Protein A affinity purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4⁰C within a week. For longer storage, aliquot and store at -20⁰C. |
| Application | ELISA; RIA; IHC; Neut |
| Application Notes | The antibody is recommended for detection of AGER by ELISA, RIA, IHC, Neut assays. |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | AGER |
| Alternative Name | Advanced Glycosylation End Product-Specific Receptor; RAGE; Receptor For Advanced Glycation End-Products Variant 20; Receptor For Advanced Glycosylation End Products; RAGE Isoform NtRAGE-Delta; RAGE Isoform SRAGE-Delta |
| Gene ID | 177 |
| UniProt | Q15109 |
| Research Area | Neuroscience |
| Related Disease | Alzheimer's disease, Central nervous system cell degeneration, Impaired learning and memory, Abnormal transport of amyloid β |
